Europe Wound Debridement Market Size, Share & Growth to 2028

Europe Wound Debridement Market Size, Share & Industry Trends Analysis Report By Mode of Purchase (Prescription, Over The Counter and Others), By Product, By Method, By Wound Type, By End-use, By Country and Growth Forecast, 2022 - 2028

Published Date: January-2023 | Number of Pages: 125 | Format: PDF | Report ID: KBV-22112

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


COVID-19

Get in-depth analysis of the COVID-19 impact on the Europe Wound Debridement Market

Market Report Description

The Europe Wound Debridement Market would witness market growth of 5.1% CAGR during the forecast period (2022-2028).

The prominent factor that is driving the growth of the market is the increase in diabetes incidences as well as the rise in wounds associated with diabetes. People who have diabetes have an increased risk of developing chronic wounds, necessitating debridement procedures. It is well-known that poor quality of life, life-threatening infections, and amputations are some of diabetic foot ulcers’ dangerous consequences.

In addition, diabetic wounds may heal slowly and become long-lasting, as they can also reoccur even after healing. Therefore, wound debridement procedures become extremely important and even lifesaving in the case of diabetic wounds. Consequently, with the rising diabetic population of the world, incidences of chronic wounds are further expected to increase.

According to recent publications by the International Diabetes Federation (IDF), the diabetic population in the world will grow to around 783 million by 2045 and 643 million in 2030 from the present figures of 537 million in 2021. The same report also stated that approximately 541 million adults in the world are at risk of acquiring type 2 diabetes.

According to the WHO, diabetes prevalence is rising in the region, with approximately 10 to 12 % of the population of the European Union’s Member States suffering from the disease. This increase in prevalence is in tandem with the growing trends of obesity and overweight, physical inactivity, socioeconomic disadvantage, and unhealthy diets. In addition to diabetes, these risk factors propel the development of noncommunicable diseases (NCDs) like chronic respiratory disease, cardiovascular diseases, and cancer.

The Germany market dominated the Europe Wound Debridement Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $401.9 million by 2028. The UK market is anticipated to grow at a CAGR of 4.2% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 5.9% during (2022 - 2028).

Based on Mode of Purchase, the market is segmented into Prescription, Over The Counter and Others. Based on Product, the market is segmented into Medical Gauzes, Gels, Surgical Devices, Ultrasonic Devices, Ointments & Creams and Others. Based on Method, the market is segmented into Surgical, Autolytic, Enzymatic, Mechanical and Others. Based on Wound Type, the market is segmented into Diabetic Foot Ulcers, Pressure Ulcers, Burn Wounds and Venous Leg Ulcers & Others. Based on End-use, the market is segmented into Hospitals, Homecare and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Wound Debridement Market will Hit $6.1 Billion by 2028, at a CAGR of 5.5%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Coloplast Group, Medline Industries, Inc., Smith & Nephew PLC, Medtronic PLC, ConvaTec Group PLC, Integra LifeSciences Holdings Corporation (Derma Sciences, Inc.), Johnson & Johnson (Ethicon, Inc.), Baxter International, Inc., and Molnlycke Health Care AB.

Scope of the Study

Market Segments Covered in the Report:

By Mode of Purchase

  • Prescription
  • Over The Counter
  • Others

By Product

  • Medical Gauzes
  • Gels
  • Surgical Devices
  • Ultrasonic Devices
  • Ointments & Creams
  • Others

By Method

  • Surgical
  • Autolytic
  • Enzymatic
  • Mechanical
  • Others

By Wound Type

  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Burn Wounds
  • Venous Leg Ulcers & Others

By End-use

  • Hospitals
  • Homecare
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • 3M Company
  • Coloplast Group
  • Medline Industries, Inc.
  • Smith & Nephew PLC
  • Medtronic PLC
  • ConvaTec Group PLC
  • Integra LifeSciences Holdings Corporation (Derma Sciences, Inc.)
  • Johnson & Johnson (Ethicon, Inc.)
  • Baxter International, Inc.
  • Molnlycke Health Care AB

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Wound Debridement Market Report 2022-2028

North America Wound Debridement Market Report 2022-2028

Asia Pacific Wound Debridement Market Report 2022-2028

LAMEA Wound Debridement Market Report 2022-2028

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities